These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

790 related items for PubMed ID: 19576852

  • 1. Hit finding: towards 'smarter' approaches.
    Langer T, Hoffmann R, Bryant S, Lesur B.
    Curr Opin Pharmacol; 2009 Oct; 9(5):589-93. PubMed ID: 19576852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Recent progress in fragment-based lead discovery.
    Schulz MN, Hubbard RE.
    Curr Opin Pharmacol; 2009 Oct; 9(5):615-21. PubMed ID: 19477685
    [Abstract] [Full Text] [Related]

  • 4. Two 'Golden Ratio' indices in fragment-based drug discovery.
    Orita M, Ohno K, Niimi T.
    Drug Discov Today; 2009 Mar; 14(5-6):321-8. PubMed ID: 19028598
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Recent trends in library design: 'rational design' revisited.
    Schnur DM.
    Curr Opin Drug Discov Devel; 2008 May; 11(3):375-80. PubMed ID: 18428091
    [Abstract] [Full Text] [Related]

  • 8. Small-world phenomena in chemical library networks: application to fragment-based drug discovery.
    Tanaka N, Ohno K, Niimi T, Moritomo A, Mori K, Orita M.
    J Chem Inf Model; 2009 Dec; 49(12):2677-86. PubMed ID: 19961207
    [Abstract] [Full Text] [Related]

  • 9. Fragment-based ligand discovery.
    Fischer M, Hubbard RE.
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [Abstract] [Full Text] [Related]

  • 10. Hit discovery and hit-to-lead approaches.
    Keseru GM, Makara GM.
    Drug Discov Today; 2006 Aug; 11(15-16):741-8. PubMed ID: 16846802
    [Abstract] [Full Text] [Related]

  • 11. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB, DeCaprio D.
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [Abstract] [Full Text] [Related]

  • 12. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T.
    Methods Enzymol; 2011 Jun; 493():469-85. PubMed ID: 21371602
    [Abstract] [Full Text] [Related]

  • 13. Recent trends and observations in the design of high-quality screening collections.
    Renner S, Popov M, Schuffenhauer A, Roth HJ, Breitenstein W, Marzinzik A, Lewis I, Krastel P, Nigsch F, Jenkins J, Jacoby E.
    Future Med Chem; 2011 Apr; 3(6):751-66. PubMed ID: 21554080
    [Abstract] [Full Text] [Related]

  • 14. Which aspects of HTS are empirically correlated with downstream success?
    Bender A, Bojanic D, Davies JW, Crisman TJ, Mikhailov D, Scheiber J, Jenkins JL, Deng Z, Hill WA, Popov M, Jacoby E, Glick M.
    Curr Opin Drug Discov Devel; 2008 May; 11(3):327-37. PubMed ID: 18428086
    [Abstract] [Full Text] [Related]

  • 15. WinDock: structure-based drug discovery on Windows-based PCs.
    Hu Z, Southerland W.
    J Comput Chem; 2007 Nov 15; 28(14):2347-51. PubMed ID: 17476686
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM, Wassermann AM, Lounkine E, Kutchukian P, Simms B, Jenkins J, Selzer P, Glick M.
    Drug Discov Today; 2013 Jul 15; 18(13-14):674-80. PubMed ID: 23454345
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Novel prostaglandin D synthase inhibitors generated by fragment-based drug design.
    Hohwy M, Spadola L, Lundquist B, Hawtin P, Dahmén J, Groth-Clausen I, Nilsson E, Persdotter S, von Wachenfeldt K, Folmer RH, Edman K.
    J Med Chem; 2008 Apr 10; 51(7):2178-86. PubMed ID: 18341273
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.